|
|||||
|
|
Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer |
|
| Authors: | Nanxin Li Yanni Hao Jipan Xie Peggy L Lin Zhou Zhou Yichen Zhong |
| Institution: | 1. Analysis Group Inc., Boston, MA, USA;2. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;3. Analysis Group Inc., New York, NY, USA |
| Abstract: | |
| Keywords: | Chemotherapy Endocrine therapy Everolimus HR+/HER2- metastatic breast cancer Treatment patterns |